Abstract:
Crohn’s disease cannot be healed but just taken into remission. Intestinal obstruction and fistulization, lack of response to medical management and perianal disease are the most frequent indication for intestinal surgery.
Why is it necessary to measure quality of life after surgery for Crohn’s disease? Firstly, morbidity and mortality provide a partial and, very often, incomplete picture of outcome. Secondarily, nowadays, indications for surgery for Crohn’s disease are broader and not limited to life saving procedures but in many cases they include chronic conditions such as failure of medical therapy, or poor quality of life on it self. Finally, quality of life is a more patient orientated measure of outcome that can give the patients’ point of view about the procedure that is proposed.
HRQL is a multi-dimensional concept which includes several dimensions based on biological and symptom variables. Disease-related worries and concerns about the disease on itself and its therapy reflect one of these dimensions and they are considered to be a major determinant of HRQL in patients with IBD. In fact, concerns about having surgery and having an ostomy bag have a relevant impact on HRQL of Crohn’s disease patients and having surgery increases concerns about body stigma.
The early impact of surgery on HRQL is an important component of the patient’s decision regarding immediate and future surgery and understanding his or her recovery. Obviously, HRQL is expected to improve after operative procedures. In effect, in most of the studies, a significant improvement in HRQL early in the postoperative period was observed. Improvement, apparently, occurred irrespective of the disease activity measured with CDAI, the indication for surgery, type of procedure (abdominal or perineal), and history of previous surgery.
On the contrary, the long-term impact of surgery on HRQL is more controversial. Some studies, mainly those performed with generic questionnaires, reported an improved HRQL while other (those performed with disease specific instruments) described a decreased HRQL. According to these authors, HRQL, apparently, depends mainly on the long-term disease activity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alison PJ, Locker D, Feine JS. (1997). Soc Sci Med. 45: 221–230.
Andersson P, Olaison G, Bendtsen P Myrelid P, Sjodahl R. (2003). Colorectal Dis. 5: 56–62.
Bechi P, Tonelli L. (1982). Int Surg. 67: 325–328.
Blondel-Kucharski F, Chircop C, Marquis P, Cortot A, Baron F, Gendre JP, Colombel JF. (2001). Groupe d'Etudes Thérapeutique des Affections Inflammatoires Digestives (GETAID) Am J Gastroenterol. 96: 2915–2920.
Broering DC, Eisenberger CF, Koch A, Bloechle C, Knoefel WT, Dürig M, Raedler A, Izbicki JR. (2001). Int J Colorectal Dis. 16: 81–87.
Canavan C, Abrams KR, Hawthorne B, Drossman D, Mayberry JF. (2006). Aliment Pharmacol Ther. 23: 377–385.
Casellas F, Lopez-Vivancos J, Badia X, Vilaseca J, Malagelada JR. (2001). Eur J Gastroenterol Hepatol. 13: 567–572.
Casellas F, López-Vivancos J, Badia X, Vilaseca J, Malagelada JR. (2000). Am J Gastroenterol. 95: 177–182.
Casellas F, López-Vivancos J, Vergara M, Malagelada J. (1999). Dig Dis.17: 208–218.
Cooper JC, Jones D, Williams NS. (1986). Ann R Coll Surg Engl. 68: 279–282.
Delaney CP, Kiran RP, Senagore AJ, O’Brien-Ermlich B, Church J, Hull TL, Remzi FH, Fazio VW. (2003). J Am Coll Surg. 196: 714–721.
Delaney CP, Fazio VW. (2001). Surg Clin North Am. 81: 137–158.
De Rooy EC, Toner BB, Maunder RG, Greenberg GR, Baron D, Steinhart AH, McLeod RS, Cohen Z. (2001). Am J Gastroenterol. 96: 1816–1821.
Drossman DA, Leserman J, Li ZM, Mitchell CM, Zagami EA, Patrick DL. (1991). Psychosom Med. 53: 701–712.
Drossman DA, Patrick DL, Mitchell CM, Zagami E, Applebaum MI. (1989). Dig Dis Sci. 34: 1379–1386.
Dunker MS, Stiggelbout AM, van Hogezand RA, Ringers J, Griffioen G, Bemelman WA. (1998). Surg Endosc. 12: 1334–1340.
Etienney I, Bouhnik Y, Gendre JP, Lemann M, Cosnes J, Matuchansky C, Beaugerie L, Modigliani R, Rambaud JC. (2004). Gastroenterol Clin Biol. 28: 1233–1239.
Fazio VW, O’Riordain MG, Lavery IC, Church JM, Lau P, Strong SA, Hull T. (1999). Ann Surg. 1230: 575–586.
Guassora AD, Kruuse C, Thomsen OO, Binder V. (2000). Scand J Gastroenterol. 35: 1068–1074.
Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, Tompkins C. (1989). Gastroenterology. 96(3): 804–810.
Hjortswang H, Almer S, Strom M. (1999). Eur J Gastroenterol Hepatol. 11: 1099–1104.
Irvine EJ. (1994). Gastroenterology. 106: 287–296.
Kiran RP, Delaney CP, Senagore AJ, O’Brien-Ermlich B, Mascha E, Thornton J, Fazio VW. (2003). Am J Gastroenterol. 98(8): 1783–1789.
Kirshner J. (1980). JAMA. 243: 557–563.
Levenstein S, Li Z, Almer S, Barbosa A, Marquis P, Moser G, Sperber A, Toner B, Drossman DA. (2001). Am J Gastroenterol. 96: 1822–1830.
Lindhagen T, Ekelund G, Leandoer L, Hildell J, Lindström C, Wenckert A. (1983). Acta Chir Scand. 149: 415–421.
Maartense S, Dunker MS, Slors JF, Cuesta MA, Pierik EG, Gouma DJ, Hommes DW, Sprangers MA, Bemelman WA. (2006). Ann Surg. 243: 143–149.
Martin A, Leone L, Fries W, Naccarato R. (1995). Ital J Gastroenterol. 27: 450–454.
Maunder RG, Toner B, de Rooy E, Moskovitz D. (1999). Can J Gastroenterol. 13: 728–732.
Maunder RG, Cohen Z, McLeod RS, Greenberg GR. (1995). Dis Colon Rectum. 38: 1147–1161.
McLeod RS (1999). Adv Surg. 33: 293–309.
McLeod RS, Baxter NN. (1998). World J Surg. 28: 375–381.
McLeod RS, Churchill DN, Lock AM. (1991). Gastroenterology. 101: 1307–1313.
Meyers S. (1983). Mt Sinai J Med. 50: 190–192.
Meyers S, Walfish JS, Sachar DB, Greenstein AJ, Hill AG, Janowitz HD. (1980). Gastroenterology. 78: 1–6.
Moser G, Tillinger W, Sachs G, Genser D, Maier-Dobersberger T, Spiess K, Wyatt J, Vogelsang H, Lochs H, Gangl A. (1995). Eur J Gastroenterol Hepatol. 7: 853–858.
Mussell M, Bocker U, Nagel N, Singer MV. (2004). Eur J Gastroenterol Hepatol. 16: 1273–1280.
Nissan A, Zamir O, Spira RM, Seror D, Alweiss T, Beglaibter N, Eliakim R, Rachmilewitz D, Freund HR. (1997). Am J Surg. 174: 339–341.
Scarpa M, Ruffolo C, D’Incà R, Filosa T, Bertin E, Ferraro S, Polese L, Martin A, Sturniolo GC, Frego M, D’Amico DF, Angriman I. (2007a). Inflamm Bowel Dis. 13(4): 462–469.
Scarpa M, Ruffolo C, Polese L, Martin A, D’Incà R, Sturniolo GC, D’Amico DF, Angriman I. (2007b). Arch Surg. 142(2): 158–165.
Scarpa M, Angriman I, Ruffolo C, Ferronato A, Polese L, Barollo M, Martin A, Sturniolo GC, D'Amico DF. (2004). World J Surg. 58(2): 122–126.
Scott NA, Hughes LE. (1994). Gut. 35: 656–657.
Thaler K, Dinnewitzer A, Oberwalder M, Weiss EG, Nogueras JJ, Wexner SD. (2005). Colorectal Dis. 7: 375–381.
Thirlby RC, Sobrino MA, Randall JB. (2001). Arch Surg. 136: 521–527.
Thirlby RC, Land JC, Fenster LF, Lonborg R. (1998). Arch Surg. 133: 826–832.
Tillinger W, Mittermaier C, Lochs H, Moser G. (1999). Dig Dis Sci. 44: 932–938.
Yazdanpanah Y, Klein O, Gambiez L, Baron P, Desreumaux P, Marquis P, Cortot A, Quandalle P, Colombel JF. (1997). Am J Gastroenterol. 92: 1897–1900.
Wolff BG. (1998). World J Surg. 22: 364–369.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
Scarpa, M., Angriman, I. (2010). Health-Related Quality of Life After Surgery for Crohn’s Disease. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_135
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_135
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine